Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jennie L. Yee"'
Publikováno v:
Journal of Neuro-Oncology. 134:325-330
Given prior studies that suggest the use of angiotensin system inhibitors (ASIs) is associated with prolonged overall survival (OS) in glioblastoma (GBM) patients, we evaluated the effect of ASIs in glioma patients receiving chemotherapy and/or bevac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e425fcd5c5523f6dc6e753b30366ba2a
https://doi.org/10.1007/s11060-017-2528-3
https://doi.org/10.1007/s11060-017-2528-3
Autor:
Rita L. Hui, Nancy D. Mendelssohn, Mady C. Stovall, Scott Peak, Jennie L. Yee, Victor A. Levin, David M. Chen, James Chan
Publikováno v:
Journal of Neuro-Oncology. 122:145-150
Bevacizumab (BEV, Avastin(®)) produces durable objective radiological responses of 20-26 %, median response durations of 16-18 weeks, and median overall survival (mOS) of 31-40 weeks. While the use of BEV is well-established, the lack of dose-respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0388676d52bbe2b38b1d309822215443
https://doi.org/10.1007/s11060-014-1693-x
https://doi.org/10.1007/s11060-014-1693-x
Publikováno v:
Annals of Pharmacotherapy. 40:1293-1300
Objective: TO describe the pharmacology, efficacy, and safety of ziconotide for treatment of severe chronic pain in patients who are candidates for intrathecal therapy. Data Sources: A PubMed/MEDLINE search (1966–June 2006) was conducted using the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc94c848386ccaf755bb17e00e5b621a
https://doi.org/10.1345/aph.1g584
https://doi.org/10.1345/aph.1g584
Publikováno v:
Annals of Pharmacotherapy. 39:1990-1995
BACKGROUND Given that adverse drug events result in extensive costs and healthcare resource utilization, the goal is to better understand drug-related emergency department (ED) visits so that programs can be implemented to improve the quality of heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52437115e55574ca64365233b3171a25
https://doi.org/10.1345/aph.1e541
https://doi.org/10.1345/aph.1e541
Publikováno v:
The Annals of pharmacotherapy. 40(7-8)
To describe the pharmacology, efficacy, and safety of ziconotide for treatment of severe chronic pain in patients who are candidates for intrathecal therapy.A PubMed/MEDLINE search (1966-June 2006) was conducted using the terms ziconotide, Prialt, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98a3987fab97704a1e71aa4db1f9da5b
https://pubmed.ncbi.nlm.nih.gov/16849624
https://pubmed.ncbi.nlm.nih.gov/16849624